Write in a clean editor, then format for Clinical and Translational Medicine in one click — DocuGuru applies the official Springer Nature template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Clinical and Translational Medicine is a peer-reviewed journal published by Springer Nature, covering Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Single-cell and spatial transcriptomics.
| Publisher | Springer Nature |
|---|---|
| Reference style | Numbered (Springer Basic) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C (2023) A representative article title. Clinical and Translational Medicine 12:45–58
Formats any DOI in Clinical and Translational Medicine style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Single-cell and spatial transcriptomics Immune cells in cancer RNA modifications and cancer |
| ISSN | 2001-1326 |
| Citation impact (2-yr) | 6.3 |
| h-index | 104 |
| i10-index | 1,396 |
| Total citations | 66,454 |
| Article processing charge | $3,000 |
| Open access | Yes |
| Top institutions publishing here | Sun Yat-sen University |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Single-cell RNA sequencing (scRNA-seq) technology has become the state-of-the-art approach for unravelling the heterogeneity and complexity of RNA transcripts within individual cells, as well as revealing the composition of different cell types and functions within highly organized tissues/organs/organisms. Since its first discovery in 2009, studies based on scRNA-seq provide massive information across different fields making…
Abstract Cancer continues to be one of the most difficult global healthcare problems. Although there is a large library of drugs that can be used in cancer treatment, the problem is selectively killing all the cancer cells while reducing collateral toxicity to healthy cells. There are several biological barriers to effective drug delivery in cancer…
EMT and MET comprise the processes by which cells transit between epithelial and mesenchymal states, and they play integral roles in both normal development and cancer metastasis. This article reviews these processes and the molecular pathways that contribute to them. First, we compare embryogenesis and development with cancer metastasis. We then discuss the signaling pathways…
Chemotherapy is one of the standard methods of treatment in many cancers. While chemotherapy is often capable of inducing cell death in tumors and reducing the tumor bulk, many cancer patients experience recurrence and ultimately death because of treatment failure. In recent years, cancer stem cells (CSCs) have gained intense interest as key tumor-initiating cells…
Diseases of infection, of neurodegeneration (such as Alzheimer's and Parkinson's diseases), and of malignancy (cancers) have complex and varied causative factors. Modern drug discovery has the power to identify potential modulators for multiple targets from millions of compounds. Computational approaches allow the determination of the association of each compound with its target before chemical synthesis…
